Stage Is Not a Reliable Indicator of Tumor Volume in Non-small Cell Lung Cancer: A Preliminary Analysis of the Trans-Tasman Radiation Oncology Group 99-05 Database
- 1 September 2006
- journal article
- Published by Elsevier in Journal of Thoracic Oncology
- Vol. 1 (7) , 667-672
- https://doi.org/10.1097/01243894-200609000-00011
Abstract
No abstract availableThis publication has 11 references indexed in Scilit:
- Prognostic factors for survival in stage III non–small-cell lung cancer treated with definitive radiation therapy: Impact of tumor volumeInternational Journal of Radiation Oncology*Biology*Physics, 2006
- Failure of T stage to predict survival in patients with non-small-cell lung cancer treated by radiotherapy with or without concomitant chemotherapyInternational Journal of Radiation Oncology*Biology*Physics, 2002
- Measurement of lung tumor volumes using three-dimensional computer planning softwareInternational Journal of Radiation Oncology*Biology*Physics, 2002
- Gross tumor volume, critical prognostic factor in patients treated with three-dimensional conformal radiation therapy for non-small-cell lung carcinomaInternational Journal of Radiation Oncology*Biology*Physics, 2002
- Stage distribution in patients with a small (? 3 cm) primary nonsmall cell lung carcinomaCancer, 2001
- Sympercents: symmetric percentage differences on the 100 loge scale simplify the presentation of log transformed dataStatistics in Medicine, 2000
- Radiosensitization With Carboplatin for Patients With Unresectable Stage III Non–Small-Cell Lung Cancer: A Phase III Trial of the Cancer and Leukemia Group B and the Eastern Cooperative Oncology GroupJournal of Clinical Oncology, 1999
- Tumor volume: a basic and specific response predictor in radiotherapyRadiotherapy and Oncology, 1998
- Confirmation of a prognostic index for patients with inoperable non-small cell lung cancerRadiotherapy and Oncology, 1997
- Volume and dose parameters for survival of non-small cell lung cancer patientsRadiotherapy and Oncology, 1997